News

Deal Announcements

Accera Accepts Venture Capital Investment

Monday, October 15, 2012 5:34:00 AM PDT | VentureDeal
Broomfield, Colorado  --  Biotechnology company Accera has secured $6.9 million in new venture capital equity financing, according to an SEC filing.

Accera is discovering new therapeutic treatments for neurodegenerative diseases of the central nervous system.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1